152 related articles for article (PubMed ID: 37222476)
1. Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.
Fischer U; Koga M; Strbian D; Branca M; Abend S; Trelle S; Paciaroni M; Thomalla G; Michel P; Nedeltchev K; Bonati LH; Ntaios G; Gattringer T; Sandset EC; Kelly P; Lemmens R; Sylaja PN; Aguiar de Sousa D; Bornstein NM; Gdovinova Z; Yoshimoto T; Tiainen M; Thomas H; Krishnan M; Shim GC; Gumbinger C; Vehoff J; Zhang L; Matsuzono K; Kristoffersen E; Desfontaines P; Vanacker P; Alonso A; Yakushiji Y; Kulyk C; Hemelsoet D; Poli S; Paiva Nunes A; Caracciolo N; Slade P; Demeestere J; Salerno A; Kneihsl M; Kahles T; Giudici D; Tanaka K; Räty S; Hidalgo R; Werring DJ; Göldlin M; Arnold M; Ferrari C; Beyeler S; Fung C; Weder BJ; Tatlisumak T; Fenzl S; Rezny-Kasprzak B; Hakim A; Salanti G; Bassetti C; Gralla J; Seiffge DJ; Horvath T; Dawson J;
N Engl J Med; 2023 Jun; 388(26):2411-2421. PubMed ID: 37222476
[TBL] [Abstract][Full Text] [Related]
2. Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.
Ray WA; Chung CP; Stein CM; Smalley W; Zimmerman E; Dupont WD; Hung AM; Daugherty JR; Dickson A; Murray KT
JAMA; 2021 Dec; 326(23):2395-2404. PubMed ID: 34932078
[TBL] [Abstract][Full Text] [Related]
3. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
Goeldlin MB; Hakim A; Branca M; Abend S; Kneihsl M; Valenzuela Pinilla W; Fenzl S; Rezny-Kasprzak B; Rohner R; Strbian D; Paciaroni M; Thomalla G; Michel P; Nedeltchev K; Gattringer T; Sandset EC; Bonati L; Aguiar de Sousa D; Sylaja PN; Ntaios G; Koga M; Gdovinova Z; Lemmens R; Bornstein NM; Kelly P; Katan M; Horvath T; Dawson J; Fischer U;
JAMA Neurol; 2024 May; ():. PubMed ID: 38805207
[TBL] [Abstract][Full Text] [Related]
4. Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation.
Yang Y; Kim M; Kim J; Cho MS; Lee S; Song JM; Kim DH
J Am Heart Assoc; 2024 Feb; 13(3):e032272. PubMed ID: 38293966
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
[TBL] [Abstract][Full Text] [Related]
6. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
Healey JS; Lopes RD; Granger CB; Alings M; Rivard L; McIntyre WF; Atar D; Birnie DH; Boriani G; Camm AJ; Conen D; Erath JW; Gold MR; Hohnloser SH; Ip J; Kautzner J; Kutyifa V; Linde C; Mabo P; Mairesse G; Benezet Mazuecos J; Cosedis Nielsen J; Philippon F; Proietti M; Sticherling C; Wong JA; Wright DJ; Zarraga IG; Coutts SB; Kaplan A; Pombo M; Ayala-Paredes F; Xu L; Simek K; Nevills S; Mian R; Connolly SJ;
N Engl J Med; 2024 Jan; 390(2):107-117. PubMed ID: 37952132
[TBL] [Abstract][Full Text] [Related]
7. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
[TBL] [Abstract][Full Text] [Related]
8. Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.
Labovitz AJ; Rose DZ; Fradley MG; Meriwether JN; Renati S; Martin R; Kasprowicz T; Murtagh R; Kip K; Beckie TM; Stoddard M; Bozeman AC; McTigue T; Kirby B; Tran N; Burgin WS;
Stroke; 2021 Apr; 52(4):1164-1171. PubMed ID: 33626904
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study.
Holbrook A; Morrow R; Lee AYY; Foster G; Pullenyegum E
J Popul Ther Clin Pharmacol; 2020 Apr; 27(2):e28-e44. PubMed ID: 32320170
[TBL] [Abstract][Full Text] [Related]
10. Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
Kimura S; Toyoda K; Yoshimura S; Minematsu K; Yasaka M; Paciaroni M; Werring DJ; Yamagami H; Nagao T; Yoshimura S; Polymeris A; Zietz A; Engelter ST; Kallmünzer B; Cappellari M; Chiba T; Yoshimoto T; Shiozawa M; Kitazono T; Koga M;
Stroke; 2022 May; 53(5):1540-1549. PubMed ID: 35105180
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
Kirchhof P; Toennis T; Goette A; Camm AJ; Diener HC; Becher N; Bertaglia E; Blomstrom Lundqvist C; Borlich M; Brandes A; Cabanelas N; Calvert M; Chlouverakis G; Dan GA; de Groot JR; Dichtl W; Kravchuk B; Lubiński A; Marijon E; Merkely B; Mont L; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Sznajder R; Velchev V; Wichterle D; Sehner S; Simantirakis E; Lip GYH; Vardas P; Schotten U; Zapf A; ;
N Engl J Med; 2023 Sep; 389(13):1167-1179. PubMed ID: 37622677
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.
Dogliotti A; Paolasso E; Giugliano RP
Clin Cardiol; 2013 Feb; 36(2):61-7. PubMed ID: 23338902
[TBL] [Abstract][Full Text] [Related]
14. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
Miao B; Alberts MJ; Bunz TJ; Coleman CI
J Thromb Thrombolysis; 2019 Oct; 48(3):366-372. PubMed ID: 31228038
[TBL] [Abstract][Full Text] [Related]
16. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial.
Wang K; Li H; Kwong WJ; Antman EM; Ruff CT; Giugliano RP; Cohen DJ; Magnuson EA;
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862934
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.
Hong KS; Kwon SU; Lee SH; Lee JS; Kim YJ; Song TJ; Kim YD; Park MS; Kim EG; Cha JK; Sung SM; Yoon BW; Bang OY; Seo WK; Hwang YH; Ahn SH; Kang DW; Kang HG; Yu KH;
JAMA Neurol; 2017 Oct; 74(10):1206-1215. PubMed ID: 28892526
[TBL] [Abstract][Full Text] [Related]
20. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
